The world of celiac disease research changes and evolves each and every day. Beyond Celiac keeps the community up-to-date on research in many ways, including our Research News Feed and the Research Opt-In.
Only 10 percent of nearly 224,000 children who had a symptom or condition that should have led to celiac disease testing were actually tested, Beyond Celiac research found.
Beyond Celiac recently presented three posters that provide evidence that screening for celiac disease is not taking place as often as it should, that neurological symptoms are frequent and severe and that those with celiac disease are often exposed to gluten, which impacts their social interactions and work.
Beyond Celiac and the American Gastroenterological Associate partnered to bring important updates in celiac disease research, management and more to patients through patient-friendly summaries of recent articles published by AGA.
For those with celiac disease, an endoscopy and biopsy may not be a major barrier to participating in clinical trials and intestinal healing is an important result when celiac disease patients consider potential treatments, Beyond Celiac research finds.
Nearly one in four non-Hispanic Black Americans who have conditions that should lead to a test for celiac disease never get one, according to data presented by Beyond Celiac at the International Celiac Disease Symposium.
A potential celiac disease vaccine could one day be a reality. Whenever new information is available we update our Research News and our Celiac Disease Vaccine page.
Researchers around the world are working to develop new treatments for celiac disease. As a person affected by celiac disease, you can play an important role in advancing research by participating in clinical trials. View our Clinical Trials Infographic to learn how clinical trials tie into to drug development process.
Additionally, Beyond Celiac has been directly involved with assisting a number of clinical studies in all phases. With the largest celiac disease social community, a robust email and research database and a website that receives over 2 million visits a year, we are uniquely qualified to help your clinical trial recruit qualified candidates. Learn about our patient recruitment offerings.
Our Chief Scientific Officers lead the development and implementation of a transformational patient-centered research agenda focused on accelerating solutions toward new pharmaceutical treatments and a cure for celiac disease.
Our Chief Scientist and Strategy Officer develops our research and funding priorities to impact patients in areas including clinical decision-making about disease management, treatment, and eventually a cure.
Learn more about our Science Team, as well as our Medical Advisory Council and Scientific Advisory Board.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to